cover image: First do no harm : S'abstenir de faire du mal : répondre à la crise liée aux médicaments d'ordonnance au Canada

Premium

20.500.12592/mpw318

First do no harm : S'abstenir de faire du mal : répondre à la crise liée aux médicaments d'ordonnance au Canada

27 Mar 2013

The management of acute and chronic pain and the use of prescription opioids are often linked, as are the treatment of anxiety and sleep disorders and the use of benzodiazepines. [...] Effective treatment and prevention approaches need to specifically attend to the diversity of different populations, including their geographical and cultural contexts, and the many other factors that contribute to risk and the impacts of prescription drugs across the system. [...] Addressing the non-medical use of prescription drugs and related harms was identified as a priority for action during Canada-wide consultations undertaken in 2003-2004 by Health Canada and the CCSA to inform the National Framework for Action to Reduce the Harms Associated with Alcohol and other Drugs and Substances in Canada (CCSA, 2005). [...] Phases for the Work of the NAC As decided in June 2012 at the inaugural meeting of the NAC in Halifax, the work of the NAC will proceed through three phases. [...] Process for Developing the Strategy The NAC was co-chaired by the Director, Addiction Services, Nova Scotia Department of Health and Wellness; the Senior Medical Advisor, College of Physicians and Surgeons of Alberta; and the Chief Executive Officer of CCSA.
health education school mental health drugs guidelines medicine medications medical specialisation disease prescription drugs substance-related disorders drug and narcotic control therapy prevention comorbidity clinical medicine drug overdose further education addiction drug health treatment dose (biochemistry) analgesic opioids medical drugs drug diversion opioid benzodiazepine buprenorphine chronic pain medication abuse
ISBN
9781927467848
Pages
88
Published in
Canada

Related Topics

All